Synact Pharma Aps

This study tests whether a daily pill called AP1189 can help hospitalized patients with breathing failure due to viruses like flu, RSV, or COVID-19. About 96 adults will receive either AP1189 or a placebo for 14 days, on top of usual care. The main goal is to see if the drug redu…

This study tests an experimental drug called AP1189 in people with a rare kidney condition called idiopathic membranous nephropathy, which causes severe protein leakage in urine. The trial includes 23 adults who are already on standard blood pressure medications. Participants wil…

This Phase 2 trial tests an oral drug called AP1189 in 240 people with early rheumatoid arthritis who have not yet taken disease-modifying drugs. Participants receive one of three doses of AP1189 or a placebo, all alongside standard methotrexate, for 12 weeks. The goal is to see …